Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000974021 | SCV001121825 | benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000974021 | SCV001793240 | likely benign | not provided | 2020-03-30 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001819140 | SCV002068328 | benign | not specified | 2018-04-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000974021 | SCV002497768 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | TUBGCP4: BS2 |
Ambry Genetics | RCV002548386 | SCV003596307 | likely benign | Inborn genetic diseases | 2021-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000974021 | SCV005214586 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003918540 | SCV004744981 | benign | TUBGCP4-related disorder | 2019-08-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |